End-stage Renal Disease Clinical Trial
Official title:
Effect of Restriction of Foods Containing Phosphorus Additives on the Phosphatemia of Patients With End-stage Renal Disease.
Hyperphosphatemia is related to the increase in morbidity and mortality. There is greater
risk for cardiovascular disease, atherosclerotic disease, secondary hyperparathyroidism, and
bone disease .
The serum phosphorus level can be controlled by a combination of factors, such as: reduction
of ingestion, reduction of intestinal absorption with chelating agents and increase in
elimination by dialysis.
The purpose of this study is to evaluate the effect of dietary intervention consisting of
the restriction of industrialized foods with phosphorus additives in chronic kidney disease
patients treated with hemodialysis.
The consumption of foods which contain phosphorus by patients on hemodialysis should be
monitored in order to reflect the current reality, due to the increase in ingestion of
industrialized foods rich in phosphorus additives. Data from studies performed in the USA
shows a reduction in phosphatemia with nutritional orientation to reduce foods containing
additives from restaurants in the region of the study . In another study, also conducted in
the USA, the researchers evaluated the phosphorus content and presence of additives in
appetizers and side orders served at fast food restaurants in Cleveland. The results showed
that of the appetizers, 52% were accepted by the traditional criteria for the renal diet
(low content of sodium, potassium and organic or natural phosphorus), but only 16% were also
free of phosphorus additives; of the side orders, 23% were accepted by the traditional
criteria and 17% were exempt of phosphorus additives. Thus, only a small proportion of
appetizers and side orders served at fast food restaurants were compatible with the renal
diet. Considering that alimentary phosphorus has an important role in the control of
phosphatemia, there is a lack of studies which evaluates the effect of foods containing
phosphorus additives on phosphatemia and which, at the same time, evaluated the alimentary
ingestion and the nutritional state of the chronic kidney disease patients treated with
hemodialysis.
Can the elimination of foods containing phosphorus additives and their substitution for
foods without additives reduce phosphatemia without altering the nutritional state of
hyperphosphatemic patients on hemodialysis?
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04087213 -
Study of HemoCareā¢ Hemodialysis System for Home Nocturnal Dialysis in Patients With ESRD
|
N/A | |
Completed |
NCT02207088 -
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
|
Phase 3 | |
Not yet recruiting |
NCT03090828 -
Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease
|
N/A | |
Completed |
NCT02237521 -
The Effect of the Incretin Hormones on the Endocrine Pancreatic Function During Hyperglycemia in End-stage Renal Disease
|
N/A | |
Withdrawn |
NCT01691196 -
Inflammation in Peritoneal Dialysis Patients: Effect of Obesity
|
||
Completed |
NCT01394341 -
Liraglutide Treatment to Patients With Severe Renal Insufficiency
|
Phase 4 | |
Active, not recruiting |
NCT00247507 -
The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
|
Phase 4 | |
Completed |
NCT00307463 -
Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation
|
Phase 4 | |
Recruiting |
NCT00155363 -
Effect of Different Hemodialysis Modality on Adiponectin,Vascular Function and Clinical Prognosis
|
Phase 4 | |
Completed |
NCT00234156 -
The Effect of Fructose on Blood Fats in Dialysis Patients and Healthy Volunteers
|
N/A | |
Completed |
NCT00586131 -
Arterial pH and Total Body Nitrogen Balances in APD
|
Phase 4 | |
Active, not recruiting |
NCT05027074 -
Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)
|
Phase 2 | |
Recruiting |
NCT04575077 -
The Role of Hepcidin as a Biomarker to Predict Successful Renal Transplantation
|
||
Enrolling by invitation |
NCT05001009 -
Goals of Care Conversations Study
|
N/A | |
Completed |
NCT01756508 -
Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury
|
Phase 2 | |
Recruiting |
NCT03862859 -
The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
|
Phase 4 | |
Terminated |
NCT03661229 -
Cardiovascular and Respiratory Assessment Using Biometric Signals in a Non-contact Monitoring Device
|
N/A | |
Completed |
NCT03288922 -
Protein-bound Toxin Removal Between Limited Blood Flow Super High-flux Online HDF and High-Efficiency Online HDF
|
N/A | |
Completed |
NCT02360748 -
A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients
|
N/A | |
Completed |
NCT02572882 -
Gut Microbiome and p-Inulin in Hemodialysis
|
N/A |